| A | B | C | D | E | F | G | H | I | J | K | L | M | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | |||||||||||||
| 2 | Name | Indication | MOA | Price | 17.63 | ||||||||
| 3 | 4D-150 | AMD, DME | aflibercept gene therapy + VEGF-C RNAi | Shares | 33.260378 | Q123 | |||||||
| 4 | 4D-710 | Cystic Fibrosis | MC | 586.3804641400001 | |||||||||
| 5 | 4D-310 | Fabry cardiomyopathy | Cash | 201.859 | Q123 | ||||||||
| 6 | 4D-125 | XLRP | Debt | 0 | Q123 | ||||||||
| 7 | 4D-110 | choroideremeia | EV | 384.52146414000003 | |||||||||
| 8 | 4D-175 | geographic atrophy | sCFH | ||||||||||
| 9 | 4D-725 | Alpha-1 antitrypsin deficiency lung disease |